You are here: Home > Founder's Desk
It is my firm belief that integration of modern scientific techniques into Ayurvedic herbal armamentarium can produce new drug molecules for India and for the world. A revisit into Ayurveda with the help of modern scientific approach from pharmaceutical era can produce very useful and safe products. Drug discovery from Ayurveda using technologies developed in the pharmaceutical era, can result in substantial number of newer molecules for modern therapeutic use.
We should adopt the modern testing and evaluation tools to identify useful herbal drug molecules.
I call upon all established Ayurvedic groups in India to work with research based groups such as Sami Labs to develop innovative therapeutic products for the molecular age.
We at Sami Labs welcome such initiatives.
Write to me at email@example.com - your input will further our commitment to good science.
Towards better health is our resolution
Dr. Muhammed Majeed
Innovation and science are what drive the Nutraceutical industry worldwide. Today, numerous clinical studies published in peer-reviewed journals for such ancient herbs as curcumin and pepper are putting previously obscure herbs in the mainstream of systemic disease prevention and treatment.
But there is a systemic disease that threatens the future of our industry by undermining investment in science and consumer confidence. There are some companies that think it's smart business to buy one kg of a patented ingredient and nine kgs of a generic "equivalent" but use the patented product claim on their marketing materials and labels. These unscrupulous marketers are exploiting the credibility of the branded ingredient to their advantage, citing clinical studies and quality criteria on the branded ingredient that are not actually applicable to the diluted product.
Manufactured products containing such diluted ingredients which fail to meet quality standards or are proved to be non-efficacious in biological testing, have detrimentally affected the credibility of the branded ingredient.
The fact that this is unethical aside, this practice cheats the consumer, and undermines investment in future innovation and clinical studies to grow the industry. Generic "equivalents" are anything but equal in quality and activity, cheating the consumer of the health benefits they expect and deserve. It also robs those companies who invest in good science from the capital to continue doing so.
Sami Lab's investment in research and patents, and the pivotal role of these efforts in garnering credibility for scientifically validated ingredients, is a case in point. For example, our BioPerine® patent brought out the concept that it is not what you eat, but what you absorb that is important in the area of nutrition. This formed the basis of a fundamental paradigm shift in how we approach supplementation. Numerous scientific publications in subsequent years validated this concept.
Another example is our C3 Complex®, the material of choice by researchers documenting the significant health benefits of curcumin because of the consistent quality we guarantee. This is truly a premium product in all senses of the word - the finest curcumin in the marketplace.
Each one of our brands, backed by scientific research, have brought little known traditional phytonutrients to the forefront, generating greater demand for these herbal extracts or nature-identical materials.
For more than two decades, Sami Labs has invested in science and innovation, and has more than 70 patents to show for it. We are committed to continuing on this path, and protecting our intellectual property in order to continue that investment. We look forward to being your partner in providing the highest quality science backed, innovation products available.
With Best Wishes,
Dr. Muhammed Majeed
Sami Labs Limited